Balancing benefits and harms in health care

This publication has 9 references indexed in Scilit:

• Malignant melanoma (non-metastatic).
  2003
• Squamous cell carcinoma of the skin (non-metastatic).
  2003
• Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials
  BMJ, 2002
• Adverse drug reactions: keeping up to date
  Fundamental & Clinical Pharmacology, 2002
• Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
  BMC Medical Research Methodology, 2001
• The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
  BMC Medical Research Methodology, 2001
• NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection
  The Lancet, 2001
• Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
  New England Journal of Medicine, 2000
• Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
  The Lancet, 1999